I concur with your rationale Fishy, although certainly not my preference for a T/O. With the big pharma's pinching a few more pennies and looking further abroad for their R&D from small fry like our little engine that could, the obvious being trial results driven, you'd be made not to put yourself in the shoes of a player in acquisitions. I would truly hate for it to pan out that way. Only M/O
I concur with your rationale Fishy, although certainly not my...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
